Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
DLL3 regulates Notch signaling in small cell lung cancer: iScience
DLL3 Targeting in Small Cell Lung Cancer | BioRender Science Templates
DLL3 – A Breakthrough Target for Small Cell Lung Cancer Therapy-DIMA ...
Dll3 cell autonomously inhibits N signaling. (A) NIH 3T3 cells ...
Investigational DLL3 & T-Cell Engager Technology for SCLC | DLL3 ...
聚焦 DLL3 靶点，有望重塑 SCLC 治疗新格局 - 知乎
Dll3 Protein Atlas at Bryan Riggs blog
Expression and therapeutic potential of DLL3 in malignancies: a ...
Impact of DLL3 Expression as Prognostic Factor in Extensive Stage of ...
Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine ...
1689 Evaluation of DLL3 Expression in Small Cell Lung Cancer by ...
DLL3 ADC峰回路转，SCLC治疗突破有望
Expression Patterns of DLL3 across Neuroendocrine and Non ...
High expression of DLL3 is associated with a poor prognosis and immune ...
DLL3 CHO Cell Line DLL3 78882
DLL3 expression in normal and tumor tissue. DLL3 protein expression via ...
Exploring the expression of DLL3 in gastroenteropancreatic ...
Biological and immunological significance of DLL3 expression in ...
2025 ASCO: Promising DLL3 ADC Data in SCLC Therapy
Expression patterns and clinical implications of PDL1 and DLL3 ...
Multi-center Assessment of DLL3 Expression by Immunohistochemistry in ...
DLL3 expressions in various cancer cell lines. (a) Examination of DLL3 ...
DLL3 Is a Prognostic and Potentially Predictive Biomarker for ...
DLL3 regulates the migration and invasion of small cell lung cancer by ...
Comparison of DLL3 expression in paired specimens of patients with ...
DLL3 antibodies - Antibody search engine - CiteAb
P3.13D.02 DLL3 Expression in Early-Stage SCLC: Comparative Analysis of ...
Elevated DLL3 in stomach cancer by tumor-associated macrophages ...
DLL3 trispecific binds to CD3 and CD137 competitively. A, Activation of ...
Representative DLL3 prevalence (ie, >1% DLL3-expressing cells) by ...
DLL3 Targeted Therapies Market, Approved Drugs Dosage, Pricing ...
Assessment of DLL3 and CD3 Expression in Pediatric Tumor FFPE Samples ...
Targeting DLL3 in Rare Neuroendocrine Carcinoma: Early Results and ...
(PDF) Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell ...
| Exemplary pictures of DLL3 staining patterns in paired chemonaive ...
CSL announces rise in full year net profit - Aug 18, 2025
Forest plots of prognostic value of DLL3 in SCLC patients. DLL3 ...
International real-world study of DLL3 expression in patients with ...
Human DLL3 Antibody AB4315: R&D Systems
Dll3 does not activate N signaling in trans. (A) Cell surface ...
LFng and Dll3 dynamically modulate N signaling. (A) NIH 3T3 cells ...
HEK293/Human DLL3 Stable Cell Line | ACROBiosystems
Frontiers | Advances in DLL3-targeted therapies for small cell lung ...
DLL3: The Next Breakthrough in Small Cell Lung Cancer
Delta-like Ligand 3 (DLL3) in Targeted Cancer Therapy
DLL3：多赛道进击小细胞肺癌 DLL3概述Delta样配体3 (Delta-Like Ligand 3, DLL3)是Notch配体家族的 ...
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary ...
Targeting DLL3: Innovative Strategies for Tumor Treatment
DLL3：肺癌治疗新希望与肿瘤研究新热点|DLL|肿瘤|表达|Notch|治疗|-健康界
Anti-DLL3 ADC - Creative Biolabs
DLL3: A New Molecular Target in Cancer - Cusabio
双抗疗法再进一步！全球首款DLL3双抗瞄准SCLC二线治疗 - 知乎
1.7亿美元首付：第一三共从默沙东引进一款DLL3/CD3双抗_财富号_东方财富网
DLL3, NOTCH1 and ASCL1 expression in small cell lung cancer (SCLC) cell ...
DLL3靶点介绍及药物研究进展-缔码生物
ESMO 2024: DLL-3 Targeted Therapy for Neuroendocrine Prostate Cancer
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade ...
传奇生物开发DLL3的CAR-T 疗法靶点项目披露 - 知乎
Characterization of DLL3-positive circulating tumor cells (CTCs) in ...
Clinical and morphological features of large-cell neuroendocrine ...
DLL3: Emerging Target in Tumor Therapy Treatment Strategies | KACTUS
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small ...
Select ongoing clinical trials of DLL3-targeted agents in SCLC ...
研发 | 一文了解DLL3研究进展-世展网
DLL3-Targeted Immunotherapy: a Competitor Analysis
研究报告 | 靶向DLL3药物在研现状 DLL3靶点介绍DLL3是一种高度肿瘤选择性的细胞表面靶点，主要表达于神经或者神经内分泌肿瘤，包括小 ...
Frontiers | Identification of DLL3-related genes affecting the ...
Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and ...
Anti-DLL3 Therapeutic Programs in Oncology – 2025 Database
Medical Crossfire®: DLL3-Driven Innovations in Small Cell Lung Cancer ...
DLL3：下一个ADC的明星靶点？ - 脉脉
Pharmacokinetics and pharmacodynamics of Tarlatamab, DLL3-Targeted FDA ...
【药海听涛】传奇的DLL3，还是DLL3的传奇？ 年底忙于俗务，连看点颇多的ESMO都来不及认真跟进，只看了一些摘要总结就有印象Amgen和 ...
小细胞肺癌的治疗靶点DLL3
针对小细胞肺癌靶向DLL3的新疗法 - 知乎
The expression levels of delta‐like 3 (DLL3) in... | Download ...
Notch-signaling and Notch-activation pathways in cancer, in relation to ...
DLL3：多赛道进击小细胞肺癌 - 知乎
Search
Frontiers | Biological Significance of NOTCH Signaling Strength
